News BioGend Therapeutics Co., Ltd.

Equities

6733

TW0006733009

End-of-day quote Taipei Exchange Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
37.9 ^TWD	+3.27%		+3.84%	-0.92%

05-28	BioGend Therapeutics Co., Ltd. Announces Hsinchu Factory Pass the Domestic Medical Device Quality Management System Manufacturing License	CI
05-10	BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioGend Therapeutics Co., Ltd. Announces Hsinchu Factory Pass the Domestic Medical Device Quality Management System Manufacturing License	05-28	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-10	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-02	CI
BioGend Therapeutics Co., Ltd. Receives Notification from the Thai FDA That Revocart to Obtains A Thai Medical Device License	02-06	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06	CI
BioGend Therapeutics Co., Ltd.(TPEX:6733) added to S&P Global BMI Index	18/09/23	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	13/05/23	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/08/22	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	10/05/22	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22	CI
BioGend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/11/21	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	09/08/21	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	09/05/21	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	15/03/21	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020	09/11/20	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	12/08/20	CI
Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	28/04/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BioGend Therapeutics Co., Ltd.

Equities

6733

TW0006733009

Summary

Filters